The Safeguard Radioligand Therapy System is an integrated, end-to-end medical device solution designed to make radioligand therapy scalable, safe, and sustainable across the full care pathway—from transport and administration to waste management.
Built to address the operational and safety challenges that limit the broader adoption of radioligand therapies (RLTs), Safeguard enables healthcare providers to deliver RLTs with reduced radiation exposure, simplified workflows, and improved environmental stewardship.
The system combines secure transport, shielded and standardized administration, and controlled radioactive waste handling into a single, cohesive platform. By minimizing manual handling and exposure risks, Safeguard supports safer working conditions for clinical staff while ensuring accurate treatment delivery.
The Safeguard system facitlitates oncology centers, outpatient clinics, and decentralized care settings to increase access to radioligand therapies. Its scalable architecture allows providers to expand treatment capacity without increasing operational complexity or safety burden.
By making radioligand therapy more accessible and easier to implement, the Safeguard Radioligand Therapy System enables to bring efficient cancer treatments closer to patients—advancing the future of precision oncology worldwide.
